Application 022395
- Type
- NDA
- Sponsor
- AVERITAS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | QUTENZA | CAPSAICIN | PATCH;TOPICAL | 8% | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 10144-928 | Qutenza | capsaicin | Acorda Therapeutics, Inc. | NDA | Current |
| 10144-929 | Qutenza | capsaicin | Acorda Therapeutics, Inc. | NDA | Current |
| 72512-928 | Qutenza | capsaicin | Averitas Pharma Inc | NDA | Current |
| 72512-928 | Qutenza | capsaicin | Averitas Pharma Inc | NDA | Current |
| 72512-928 | Qutenza | capsaicin | Averitas Pharma Inc | NDA | Current |
| 72512-928 | Qutenza | capsaicin | Averitas Pharma Inc | NDA | Current |
| 72512-929 | Qutenza | capsaicin | Averitas Pharma Inc | NDA | Current |
| 72512-929 | Qutenza | capsaicin | Averitas Pharma Inc | NDA | Current |
| 72512-929 | Qutenza | capsaicin | Averitas Pharma Inc | NDA | Current |
| 72512-929 | Qutenza | capsaicin | Averitas Pharma Inc | NDA | Current |
| 72512-930 | Qutenza | capsaicin | Averitas Pharma Inc | NDA | Current |
| 72512-930 | Qutenza | capsaicin | Averitas Pharma Inc | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79284 | SUPPL | 2024-08-02 |
| 79268 | SUPPL | 2024-08-02 |
| 73575 | SUPPL | 2023-02-21 |
| 73557 | SUPPL | 2023-02-17 |
| 71802 | SUPPL | 2022-08-15 |
| 71790 | SUPPL | 2022-08-12 |
| 68312 | SUPPL | 2021-08-06 |
| 68303 | SUPPL | 2021-08-06 |
| 64059 | SUPPL | 2020-07-23 |
| 63973 | SUPPL | 2020-07-20 |
| 63355 | SUPPL | 2020-06-01 |
| 63351 | SUPPL | 2020-05-29 |
| 44746 | ORIG | 2010-06-29 |
| 22010 | ORIG | 2010-06-29 |
| 29674 | ORIG | 2009-11-19 |
| 17309 | ORIG | 2009-11-17 |